{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:11:50Z","timestamp":1793250710325,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T00:00:00Z","timestamp":1508112000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007405","name":"The Danish Heart Foundation","doi-asserted-by":"crossref","award":["12-04-R90-A3840-22725"],"award-info":[{"award-number":["12-04-R90-A3840-22725"]}],"id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The European Foundation for the Study of Diabetes\/ Pfizer European Programme 2010 for Research into Cardiovascular Risk Reduction in Patients with Diabetes"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00592-017-1062-2","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T02:55:34Z","timestamp":1508122534000},"page":"21-29","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Arterial-ventricular coupling in type 1 diabetes: arterial stiffness is associated with impaired global longitudinal strain in type 1 diabetes patients\u2014the Thousand & 1 Study"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1151-8951","authenticated-orcid":false,"given":"Simone","family":"Theilade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan S.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus T.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,16]]},"reference":[{"key":"1062_CR1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0034-1367062","volume":"122","author":"E Matteucci","year":"2014","unstructured":"Matteucci E, Giampietro O (2014) Epidemiology of cardiovascular disease in patients with type 1 diabetes: European perspective. Exp Clin Endocrinol Diabetes 122:208\u2013214","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"Suppl 2","key":"1062_CR2","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1007\/PL00002934","volume":"44","author":"NJ Morrish","year":"2001","unstructured":"Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H (2001) Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia 44(Suppl 2):S14\u2013S21","journal-title":"Diabetologia"},{"key":"1062_CR3","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.2337\/dc06-1161","volume":"29","author":"TJ Orchard","year":"2006","unstructured":"Orchard TJ, Costacou T, Kretowski A, Nesto RW (2006) Type 1 diabetes and coronary artery disease. Diabetes Care 29:2528\u20132538","journal-title":"Diabetes Care"},{"key":"1062_CR4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229\u2013234","journal-title":"N Engl J Med"},{"key":"1062_CR5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/dme.12410","volume":"31","author":"JA Black","year":"2014","unstructured":"Black JA, Sharp SJ, Wareham NJ et al (2014) Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen-detected diabetes? Results from the ADDITION-Europe cluster randomized trial. Diabetes Med 31:647\u2013656","journal-title":"Diabetes Med"},{"key":"1062_CR6","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","volume":"358","author":"P Gaede","year":"2008","unstructured":"Gaede P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580\u2013591","journal-title":"N Engl J Med"},{"key":"1062_CR7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s005920070025","volume":"37","author":"Y Aso","year":"2000","unstructured":"Aso Y, Inukai T, Tayama K, Takemura Y (2000) Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes. Acta Diabetol 37:87\u201392","journal-title":"Acta Diabetol"},{"key":"1062_CR8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physrev.00045.2011","volume":"93","author":"JM Forbes","year":"2013","unstructured":"Forbes JM, Cooper ME (2013) Mechanisms of diabetic complications. Physiol Rev 93:137\u2013188","journal-title":"Physiol Rev"},{"key":"1062_CR9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/JOE-13-0407","volume":"221","author":"G Llaurado","year":"2014","unstructured":"Llaurado G, Ceperuelo-Mallafre V, Vilardell C et al (2014) Advanced glycation end products are associated with arterial stiffness in type 1 diabetes. J Endocrinol 221:405\u2013413","journal-title":"J Endocrinol"},{"key":"1062_CR10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/STROKEAHA.113.003305","volume":"45","author":"M Persson","year":"2014","unstructured":"Persson M, Ostling G, Smith G et al (2014) Soluble urokinase plasminogen activator receptor: a risk factor for carotid plaque, stroke, and coronary artery disease. Stroke 45:18\u201323","journal-title":"Stroke"},{"key":"1062_CR11","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","volume":"115","author":"S Boudina","year":"2007","unstructured":"Boudina S, Abel ED (2007) Diabetic cardiomyopathy revisited. Circulation 115:3213\u20133223","journal-title":"Circulation"},{"key":"1062_CR12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1056-8727(02)00275-1","volume":"17","author":"HP Hammes","year":"2003","unstructured":"Hammes HP (2003) Pathophysiological mechanisms of diabetic angiopathy. J Diabetes Complicat 17:16\u201319","journal-title":"J Diabetes Complicat"},{"key":"1062_CR13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1080\/00365510801930626","volume":"68","author":"J Kals","year":"2008","unstructured":"Kals J, Kampus P, Kals M et al (2008) Inflammation and oxidative stress are associated differently with endothelial function and arterial stiffness in healthy subjects and in patients with atherosclerosis. Scand J Clin Lab Invest 68:594\u2013601","journal-title":"Scand J Clin Lab Invest"},{"key":"1062_CR14","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1152\/japplphysiol.90549.2008","volume":"105","author":"GF Mitchell","year":"2008","unstructured":"Mitchell GF (2008) Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J Appl Physiol 105:1652\u20131660","journal-title":"J Appl Physiol"},{"key":"1062_CR15","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1093\/eurheartj\/ehl254","volume":"27","author":"S Laurent","year":"2006","unstructured":"Laurent S, Cockcroft J, Van BL et al (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27:2588\u20132605","journal-title":"Eur Heart J"},{"key":"1062_CR16","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/01.HYP.37.5.1236","volume":"37","author":"S Laurent","year":"2001","unstructured":"Laurent S, Boutouyrie P, Asmar R et al (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37:1236\u20131241","journal-title":"Hypertension"},{"key":"1062_CR17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000078149","volume":"102","author":"CO Trika","year":"2004","unstructured":"Trika CO, Zakopoulos N, Toumanidis ST, Stamatelopoulos SF, Moulopoulos SD (2004) Pulse pressure and left ventricular diastolic dysfunction in hypertensive patients. Cardiology 102:108\u2013114","journal-title":"Cardiology"},{"key":"1062_CR18","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","volume":"55","author":"C Vlachopoulos","year":"2010","unstructured":"Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55:1318\u20131327","journal-title":"J Am Coll Cardiol"},{"key":"1062_CR19","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/CIRCULATIONAHA.105.579342","volume":"113","author":"T Willum-Hansen","year":"2006","unstructured":"Willum-Hansen T, Staessen JA, Torp-Pedersen C et al (2006) Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 113:664\u2013670","journal-title":"Circulation"},{"key":"1062_CR20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1253\/circj.CJ-15-0953","volume":"80","author":"YH Chan","year":"2016","unstructured":"Chan YH, Kuo CT, Wu LS et al (2016) combined global longitudinal strain and intraventricular mechanical dyssynchrony predicts long-term outcome in patients with systolic heart failure. Circ J 80:177\u2013185","journal-title":"Circ J"},{"key":"1062_CR21","doi-asserted-by":"crossref","first-page":"e0127044","DOI":"10.1371\/journal.pone.0127044","volume":"10","author":"R Krishnasamy","year":"2015","unstructured":"Krishnasamy R, Isbel NM, Hawley CM et al (2015) Left ventricular global longitudinal strain (GLS) is a superior predictor of all-cause and cardiovascular mortality when compared to ejection fraction in advanced chronic kidney disease. PLoS ONE 10:e0127044","journal-title":"PLoS ONE"},{"key":"1062_CR22","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/1479164116637310","volume":"13","author":"MT Jensen","year":"2016","unstructured":"Jensen MT, Sogaard P, Andersen HU et al (2016) Early myocardial impairment in type 1 diabetes patients without known heart disease assessed with tissue Doppler echocardiography: the Thousand & 1 study. Diabetes Vasc Dis Res 13:260\u2013267","journal-title":"Diabetes Vasc Dis Res"},{"key":"1062_CR23","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.jacc.2011.06.038","volume":"58","author":"J Gorcsan III","year":"2011","unstructured":"Gorcsan J III, Tanaka H (2011) Echocardiographic assessment of myocardial strain. J Am Coll Cardiol 58:1401\u20131413","journal-title":"J Am Coll Cardiol"},{"key":"1062_CR24","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00125-014-3164-5","volume":"57","author":"MT Jensen","year":"2014","unstructured":"Jensen MT, Sogaard P, Andersen HU et al (2014) Prevalence of systolic and diastolic dysfunction in patients with type 1 diabetes without known heart disease: the Thousand & 1 Study. Diabetologia 57:672\u2013680","journal-title":"Diabetologia"},{"key":"1062_CR25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jcmg.2014.12.020","volume":"8","author":"MT Jensen","year":"2015","unstructured":"Jensen MT, Sogaard P, Andersen HU et al (2015) Global longitudinal strain is not impaired in type 1 diabetes patients without albuminuria: the Thousand & 1 Study. JACC Cardiovasc Imaging 8:400\u2013410","journal-title":"JACC Cardiovasc Imaging"},{"key":"1062_CR26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1530\/EJE-15-0986","volume":"174","author":"S Theilade","year":"2016","unstructured":"Theilade S, Rossing P, Eugen-Olsen J, Jensen JS, Jensen MT (2016) suPAR level is associated with myocardial impairment assessed with advanced echocardiography in patients with type 1 diabetes with normal ejection fraction and without known heart disease or end-stage renal disease. Eur J Endocrinol 174:745\u2013753","journal-title":"Eur J Endocrinol"},{"key":"1062_CR27","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440\u20131463","journal-title":"J Am Soc Echocardiogr"},{"key":"1062_CR28","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.108.815944","volume":"119","author":"DS Lee","year":"2009","unstructured":"Lee DS, Gona P, Vasan RS et al (2009) Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham heart study of the national heart, lung, and blood institute. Circulation 119:3070\u20133077","journal-title":"Circulation"},{"key":"1062_CR29","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1161\/CIRCULATIONAHA.105.561423","volume":"112","author":"SD Solomon","year":"2005","unstructured":"Solomon SD, Anavekar N, Skali H et al (2005) Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 112:3738\u20133744","journal-title":"Circulation"},{"key":"1062_CR30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","volume":"145","author":"AS Levey","year":"2006","unstructured":"Levey AS, Coresh J, Greene T et al (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247\u2013254","journal-title":"Ann Intern Med"},{"key":"1062_CR31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/ejechocard\/jep007","volume":"10","author":"SF Nagueh","year":"2009","unstructured":"Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10:165\u2013193","journal-title":"Eur J Echocardiogr"},{"key":"1062_CR32","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCULATIONAHA.106.661983","volume":"116","author":"M Kasner","year":"2007","unstructured":"Kasner M, Westermann D, Steendijk P et al (2007) Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation 116:637\u2013647","journal-title":"Circulation"},{"key":"1062_CR33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/HJH.0b013e32834fa8b0","volume":"30","author":"LM Bortel Van","year":"2012","unstructured":"Van Bortel LM, Laurent S, Boutouyrie P et al (2012) Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 30:445\u2013448","journal-title":"J Hypertens"},{"key":"1062_CR34","unstructured":"Software Operator\u2019s Guide\u2014Atcor Medical Manual. 2008"},{"key":"1062_CR35","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2337\/dc12-0850","volume":"36","author":"S Theilade","year":"2013","unstructured":"Theilade S, Lajer M, Persson F, Joergensen C, Rossing P (2013) Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes. Diabetes Care 36:715\u2013721","journal-title":"Diabetes Care"},{"key":"1062_CR36","doi-asserted-by":"crossref","first-page":"e004903","DOI":"10.1161\/JAHA.116.004903","volume":"6","author":"V Bell","year":"2017","unstructured":"Bell V, McCabe EL, Larson MG et al (2017) Relations between aortic stiffness and left ventricular mechanical function in the community. J Am Heart Assoc 6:e004903","journal-title":"J Am Heart Assoc"},{"key":"1062_CR37","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1161\/01.CIR.0000033824.02722.F7","volume":"106","author":"K Cruickshank","year":"2002","unstructured":"Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG (2002) Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 106:2085\u20132090","journal-title":"Circulation"},{"key":"1062_CR38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/01.HYP.0000111829.46090.92","volume":"43","author":"MT Schram","year":"2004","unstructured":"Schram MT, Henry RM, van Dijk RA et al (2004) Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension 43:176\u2013181","journal-title":"Hypertension"},{"key":"1062_CR39","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1210\/er.2003-0012","volume":"25","author":"ZY Fang","year":"2004","unstructured":"Fang ZY, Prins JB, Marwick TH (2004) Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25:543\u2013567","journal-title":"Endocr Rev"},{"key":"1062_CR40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","volume":"18","author":"T Miki","year":"2013","unstructured":"Miki T, Yuda S, Kouzu H, Miura T (2013) Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev 18:149\u2013166","journal-title":"Heart Fail Rev"},{"key":"1062_CR41","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s12020-012-9623-1","volume":"41","author":"X Zhang","year":"2012","unstructured":"Zhang X, Chen C (2012) A new insight of mechanisms, diagnosis and treatment of diabetic cardiomyopathy. Endocrine 41:398\u2013409","journal-title":"Endocrine"},{"key":"1062_CR42","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0024-3205(01)01141-9","volume":"69","author":"MJ Mihm","year":"2001","unstructured":"Mihm MJ, Seifert JL, Coyle CM, Bauer JA (2001) Diabetes related cardiomyopathy time dependent echocardiographic evaluation in an experimental rat model. Life Sci 69:527\u2013542","journal-title":"Life Sci"},{"issue":"1268\u20131275","key":"1062_CR43","first-page":"e1","volume":"24","author":"L Ernande","year":"2011","unstructured":"Ernande L, Bergerot C, Rietzschel ER et al (2011) Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy? J Am Soc Echocardiogr 24(1268\u20131275):e1","journal-title":"J Am Soc Echocardiogr"},{"key":"1062_CR44","first-page":"566","volume":"21","author":"H Ibsen","year":"2008","unstructured":"Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE (2008) Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes. J Nephrol 21:566\u2013569","journal-title":"J Nephrol"},{"key":"1062_CR45","doi-asserted-by":"crossref","unstructured":"de ZD, Remuzzi G, Parving HH et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004;110:921-927","DOI":"10.1161\/01.CIR.0000139860.33974.28"},{"key":"1062_CR46","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/01.CIR.0000017264.66561.3D","volume":"105","author":"J Diez","year":"2002","unstructured":"Diez J, Querejeta R, Lopez B, Gonzalez A, Larman M, Martinez Ubago JL (2002) Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 105:2512\u20132517","journal-title":"Circulation"},{"key":"1062_CR47","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1023\/A:1007754100351","volume":"12","author":"K Mitsunami","year":"1998","unstructured":"Mitsunami K, Inoue S, Maeda K et al (1998) Three-month effects of candesartan cilexetil, an angiotensin II type 1 (AT1) receptor antagonist, on left ventricular mass and hemodynamics in patients with essential hypertension. Cardiovasc Drugs Ther 12:469\u2013474","journal-title":"Cardiovasc Drugs Ther"},{"key":"1062_CR48","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.2337\/diabetes.51.4.1166","volume":"51","author":"SU Trost","year":"2002","unstructured":"Trost SU, Belke DD, Bluhm WF, Meyer M, Swanson E, Dillmann WH (2002) Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 51:1166\u20131171","journal-title":"Diabetes"},{"key":"1062_CR49","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00592-014-0619-6","volume":"51","author":"S Rosenlund","year":"2014","unstructured":"Rosenlund S, Theilade S, Hansen TW, Andersen S, Rossing P (2014) Treatment with continuous subcutaneous insulin infusion is associated with lower arterial stiffness. Acta Diabetol 51:955\u2013962","journal-title":"Acta Diabetol"},{"key":"1062_CR50","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2337\/dc13-1870","volume":"37","author":"GL Bakris","year":"2014","unstructured":"Bakris GL, Molitch M (2014) Microalbuminuria as a risk predictor in diabetes: the continuing saga. Diabetes Care 37:867\u2013875","journal-title":"Diabetes Care"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-017-1062-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-017-1062-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-017-1062-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T23:31:15Z","timestamp":1517441475000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-017-1062-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,16]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["1062"],"URL":"https:\/\/doi.org\/10.1007\/s00592-017-1062-2","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,16]]}}}